Published in
Springer, Clinical Drug Investigation, 7(43), p. 551-563, 2023
DOI: 10.1007/s40261-023-01286-3
Links
Tools
Peripheral Nerve Safety of Nerve Growth Factor Inhibition by Tanezumab: Pooled Analyses of Phase III Clinical Studies in Over 5000 Patients with Osteoarthritis
Journal article published in 2023 by
Mark T. Brown,
David R. Cornblath,
Martin Koltzenburg 
,
Kenneth C. Gorson,
Anne Hickman,
Glenn C. Pixton,
Puneet Gaitonde,
Lars Viktrup,
Christine R. West
,
Kenneth C. Gorson,
Anne Hickman,
Glenn C. Pixton,
Puneet Gaitonde,
Lars Viktrup,
Christine R. West
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 